Penn Medicine Provider
Family Medicine
Richard Charles Wender, MD
4.8
(82)
Accepting new patients
Sees patients of all ages
Penn Family Care

About me

  • Chair, Department of Family Medicine and Community Health
  • Robert G. Dunlop Professor II

Education and training

  • Medical School: University of Pennsylvania School of Medicine
  • Residency: Thomas Jefferson University Hospital

What my patients think about me

Average Rating
4.8

83 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

March 2025
5.0
5.0
a great doctor
February 2025
5.0
5.0
personable and listened to my concerns. explained the proposed treatment.
February 2025
5.0
5.0
great physician, very understanding and takes time to hear my concerns
February 2025
5.0
5.0
very professional and didn't keep me waiting

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: On the medical staff, but does not have privileges to treat patients in the hospital.
  • Pennsylvania Hospital: On the medical staff, but does not have privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Wender is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Dwyer AJ, Wender RC, Weltzien ES, Dean MS, Sharpe K, Fleisher L, Burhansstipanov L, Johnson W, Martinez L, Wiatrek DE, Calhoun E, Battaglia TA; National Navigation Roundtable Collective pursuit for equity in cancer care: The National Navigation Roundtable , Cancer, 128(Suppl 13): 2022,2561-2567


Andrea Lawful Sanders (Talk Show Host) EQUITY: What's in a WURD? , Radio Station WURD: 2022


Wender RC Should Routine Screening for Colorectal Cancer Start at 45 Years of Age? Yes: Lowering the Starting Age Is a Settled Issue. , American Family Physician: 2022


Wender RC Should Routine Screening for Colorectal Cancer Start at 45 Years of Age? Yes: Lowering the Starting Age Is a Settled Issue , Am Fam Physician, 105(2): 2022,120-121


Wender RC More social determinants lead to more cancer death: A tragic dose response , Cancer, 128(1): 2022,39-42


Wender RC, Wolf AMD Increasing Cancer Screening Rates in Primary Care , The Medical Clinics of North America, 104(6): 2020,971-987


Fontham ETH, Wolf AMD, Church TR, Etzioni R, Flowers CR, Herzig A, Guerra CE, Oeffinger KC, Shih YT, Walter LC, Kim JJ, Andrews KS, DeSantis CE, Fedewa SA, Manassaram-Baptiste D, Saslow D, Wender RC, Smith RA Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society , CA Cancer J Clin, 70(5): 2020,321-346


Wender RC Colorectal cancer screening should begin at 45. , J Gastroenterol Hepatol, 35(9): 2020,1461-1463


Giri VN, Knudsen KE, Kelly WK, Cheng HH, Cooney KA, Cookson MS, Dahut W, Weissman S, Soule HR, Petrylak DP, Dicker AP, AlDubayan SH, Toland AE, Pritchard CC, Pettaway CA, Daly MB, Mohler JL, Parsons JK, Carroll PR, Pilarski R, Blanco A, Woodson A, Rahm A, Taplin ME, Polascik TJ, Helfand BT, Hyatt C, Morgans AK, Feng F, Mullane M, Powers J, Concepcion R, Lin DW, Wender R, Mark JR, Costello A, Burnett AL, Sartor O, Isaacs WB, Xu J, Weitzel J, Andriole GL, Beltran H, Briganti A, Byrne L, Calvaresi A, Chandrasekar T, Chen DYT, Den RB, Dobi A, Crawford ED, Eastham J, Eggener S, Freedman ML, Garnick M, Gomella PT, Handley N, Hurwitz MD, Izes J, Karnes RJ, Lallas C, Languino L, Loeb S, Lopez AM, Loughlin KR, Lu-Yao G, Malkowicz SB, Mann M, Mille P, Miner MM, Morgan T, Moreno J, Mucci L, Myers RE, Nielsen SM, O'Neil B, Pinover W, Pinto P, Poage W, Raj GV, Rebbeck TR, Ryan C, Sandler H, Schiewer M, Scott EMD, Szymaniak B, Tester W, Trabulsi EJ, Vapiwala N, Yu EY, Zeigler-Johnson C, Gomella LG Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019 , J Clin Oncol., 38(24): 2020,2798-2811


Wender R, Brooks D, Sharpe K, Doroshenk M The National Colorectal Cancer Roundtable: Past Performance, Current and Future Goals. , Gastrointest Endosc Clin N Am., 30(3): 2020,499-509